Know What's Happening in Small Cap Stocks

Today's Small Cap Stocks Pulse

Deep Fission targets up to $1.66B valuation in new Nasdaq IPO

Deep Fission announced a Nasdaq IPO seeking $157 million at $24‑$26 per share, which would value the nuclear startup at up to $1.66 billion. The company previously completed a reverse merger that raised $30 million but never traded on the OTCQB. Its latest S‑1 filing shows a cash deficit of $88.1 million as of March, up from $56.2 million in December.

How We Leveraged Our Position In Russell 2000 For A Win
NewsMay 8, 2026

How We Leveraged Our Position In Russell 2000 For A Win

The trading team used the iShares Russell 2000 ETF (IWM) to gain early exposure to a small‑cap rally that began in early April, initially taking a half‑size position and scaling to just under 40% of the model portfolio by April 8....

By Investor’s Business Daily (IBD) – Markets/Business
Odyssey’s IPO Brings In $304M for Quest to Develop Better Immunology Drugs
NewsMay 8, 2026

Odyssey’s IPO Brings In $304M for Quest to Develop Better Immunology Drugs

Odyssey Therapeutics priced 15.5 million shares at $18, raising $304 million including a $25.2 million private placement. The funds will finance Phase 2a/2b trials of OD‑001, an oral RIPK2 inhibitor for ulcerative colitis, and advance OD‑002, a SLC15A4 inhibitor, toward Phase 1/2a. Odyssey’s platform targets...

By MedCity News
NI Holdings, Inc. Reports Results for First Quarter Ended March 31, 2026
NewsMay 8, 2026

NI Holdings, Inc. Reports Results for First Quarter Ended March 31, 2026

NI Holdings reported Q1 2026 results showing a 15% drop in gross premiums to $57.5 million, driven by the exit from non‑standard auto lines. The combined ratio improved to 79.7% from 94.4% a year earlier, reflecting stronger underwriting in Home, Farm...

By GlobeNewswire – Earnings Releases
Entera Announces First Quarter 2026 Financial Results and Updates Across Its Oral Peptide Programs
NewsMay 8, 2026

Entera Announces First Quarter 2026 Financial Results and Updates Across Its Oral Peptide Programs

Entera Bio reported Q1 2026 results, highlighting a streamlined Phase 3 protocol for its lead osteoporosis candidate EB613 and a completed Phase 1 bridging study that positions a single‑tablet formulation for the upcoming trial. The company also advanced its partnership with OPKO, securing...

By GlobeNewswire – Earnings Releases
Rackspace Shares Jump 83% After AMD AI Deal and Q1 Profit
NewsMay 8, 2026

Rackspace Shares Jump 83% After AMD AI Deal and Q1 Profit

Rackspace Technology (RXT) rallied 83.26% to $4.16 on Thursday after unveiling a strategic artificial‑intelligence partnership with AMD and posting a first‑quarter profit. The move turned a modest close of $2.27 into a breakout opening at $3.98, igniting short‑term trading interest.

By Pulse
Suja Life Prices $173.6M IPO at $21 per Share, Boosting Consumer‑Goods PE Pipeline
NewsMay 8, 2026

Suja Life Prices $173.6M IPO at $21 per Share, Boosting Consumer‑Goods PE Pipeline

Suja Life, the California‑based maker of plant‑based juices, priced its IPO at $21 per share, selling 8.89 million shares for roughly $173.6 million. The proceeds will fund debt repayment, employee incentives and the acquisition of its own LP units, underscoring the company's...

By Pulse
Short‑Term Pain, Long‑Term Gain: TMDX Still Bullish
SocialMay 8, 2026

Short‑Term Pain, Long‑Term Gain: TMDX Still Bullish

Just wrapped up a 45 minute call with $TMDX management… lots of good stuff.. obviously there’s some short term pain from margin compression due to bigger investments (R&D, trials, international expansion, etc) but my conviction has not changed and I...

By Jonah Lupton
Bob’s Q1 Growth Defies Wider Sector Trends
NewsMay 8, 2026

Bob’s Q1 Growth Defies Wider Sector Trends

Bob’s Discount Furniture reported an 8.5% rise in first‑quarter revenue to $578 million, helped by five new store openings and 1.2% comparable‑store growth. Net income, however, plunged 81% to $2.5 million as SG&A rose 9% and a $2 million advisory termination fee was...

By Retail Dive
Health Firms Odyssey, Mobia Fall After $454 Million IPO Haul
NewsMay 8, 2026

Health Firms Odyssey, Mobia Fall After $454 Million IPO Haul

Odyssey Therapeutics and Mobia Health debuted on the Nasdaq, together raising about $454 million—$304 million for Odyssey and $150 million for Mobia after an upsized IPO and a private placement. Despite the strong capital infusion, Odyssey’s shares fell 8.8 % in early trading, and...

By Bloomberg – Markets
San Lorenzo Hits All-Time High on Chile Gold Assays
NewsMay 8, 2026

San Lorenzo Hits All-Time High on Chile Gold Assays

San Lorenzo Gold announced breakthrough assay results from its Arco de Oro drill program at the Salvadora project in Chile, highlighting intervals of more than 1 g/t gold over 100 m, including a 13 m section grading 2.21 g/t Au. The data suggest the...

By The Northern Miner
Track Group Reports 2nd Quarter Fiscal 2026 Financial Results
NewsMay 8, 2026

Track Group Reports 2nd Quarter Fiscal 2026 Financial Results

Track Group reported Q2 FY26 revenue of $8.9 M, up 7% year‑over‑year, led by growth in Florida and Illinois. Gross profit rose 9% to $4.5 M and operating income surged 830% to $0.41 M, reflecting tighter cost controls. Non‑GAAP Adjusted EBITDA increased 18%...

By GlobeNewswire – Earnings Releases
Uber-Backed Electric Scooter Rental Firm Lime Files for IPO
NewsMay 8, 2026

Uber-Backed Electric Scooter Rental Firm Lime Files for IPO

Lime, the Uber‑backed electric scooter and e‑bike rental firm, filed for an IPO targeting a roughly $2 billion valuation. In 2025 the company generated $886.7 million in revenue but posted a $59.3 million net loss, widening from the prior year. Lime now operates...

By Transport Topics – Technology
Research Pipeline Session #19 : A Cash-Rich Industrial Quietly Pivoting Toward AI
BlogMay 8, 2026

Research Pipeline Session #19 : A Cash-Rich Industrial Quietly Pivoting Toward AI

The unnamed industrial micro‑cap has posted a dramatic earnings turnaround, with EBITDA margins expanding roughly 600 basis points and adjusted earnings per share nearly tripling in the last quarter. Its balance sheet now holds about $200 million of net cash and...

By Microcap Investing Cliff Notes
Rocket Lab Stock Surges on Revenue Win, $30M Contract
NewsMay 8, 2026

Rocket Lab Stock Surges on Revenue Win, $30M Contract

Rocket Lab Corp (NASDAQ:RKLB) surged 18.8% to $93.31 after reporting first‑quarter revenue in line with estimates and announcing a $30 million contract for three HASTE hypersonic test launches. The company also disclosed its largest launch contract ever with an undisclosed customer,...

By Schaeffer’s Investment Research – News & Analysis
Three of the Best UK Small-Cap Stocks to Buy Now
NewsMay 8, 2026

Three of the Best UK Small-Cap Stocks to Buy Now

UK small‑cap investors are targeting niche leaders that can command pricing power and sustain margins despite inflation. Moonpig (LSE:MOON) dominates the online greeting‑cards market with roughly 70% share and has built a data‑rich subscription base exceeding one million users. Victorian...

By MoneyWeek – All
Saga Communications’ Q1 Net Revenue Falls 5.6%
NewsMay 8, 2026

Saga Communications’ Q1 Net Revenue Falls 5.6%

Saga Communications reported first‑quarter 2026 net revenue of $22.9 million, a 5.6% decline from the same period a year earlier. The company posted an operating loss of $3.3 million, widening from $2.3 million in Q1 2025, while station operating income fell 62% to $900,000....

By Talkers
Forward Air Flags Customer Loss, Stock Plummets
NewsMay 8, 2026

Forward Air Flags Customer Loss, Stock Plummets

Forward Air reported a $34 million net loss for Q1 and warned that a contract‑logistics customer accounting for roughly 10% of its $2.5 billion annual revenue is diversifying away. The disclosure sent the stock down more than 40% and confirmed a strategic...

By FreightWaves
CoreWeave Stock Sinks After Forecast Miss
NewsMay 8, 2026

CoreWeave Stock Sinks After Forecast Miss

CoreWeave Inc. (CRWV) saw its shares plunge 11% after the AI‑focused data‑center operator issued a revenue outlook of $2.45‑$2.6 billion for the current quarter, missing the $2.7 billion consensus. Operating income is now projected at $30‑$90 million, well below analysts’ $154 million estimate, and...

By Yahoo Finance – News Index
Kodiak AI Raises $100M at $6.50 Share Price, Stock Slides 37%
NewsMay 8, 2026

Kodiak AI Raises $100M at $6.50 Share Price, Stock Slides 37%

Kodiak AI announced a $100 million financing at $6.50 per share, far below its $9.10 closing price, triggering a 37% plunge in after‑hours trading. The raise, led by Ares Management and unnamed institutions, underscores the valuation strain facing autonomous‑vehicle startups despite...

By Pulse
Mobia Medical Prices $150 Million IPO to Fund Stroke‑Device Platform
NewsMay 8, 2026

Mobia Medical Prices $150 Million IPO to Fund Stroke‑Device Platform

Mobia Medical, Inc. priced a 10 million‑share public offering at $15 per share, raising roughly $150 million. The Nasdaq‑listed ticker “MOBI” will debut on May 8, giving the stroke‑device firm capital to accelerate product development and market rollout.

By Pulse
Ensign Energy Services Inc. Q1 2026 Update – ESI.TO
BlogMay 8, 2026

Ensign Energy Services Inc. Q1 2026 Update – ESI.TO

Ensign Energy Services (ESI) posted Q1 2026 revenue of C$418 million (≈US$309 million), a 4% decline year‑over‑year, while adjusted EBITDA slipped 7% to C$94.8 million (≈US$70 million) and margin fell to 22.7%. The company boosted total capital expenditures 69% to C$65.3 million (≈US$48 million), emphasizing maintenance...

By Petty Cash
AAOI Down 15% Before Triple‑Digit Growth Surge
SocialMay 8, 2026

AAOI Down 15% Before Triple‑Digit Growth Surge

Nice recap of the $AAOI earnings report… it was lovely to see the stock down -15% last night when the real growth ramp doesn’t kick in for 1-2 quarters at which point $AAOI will likely be growing triple digits YoY...

By Jonah Lupton
INBX to Release INBRX‑106 Phase 2 Data Monday
SocialMay 8, 2026

INBX to Release INBRX‑106 Phase 2 Data Monday

$INBX reporting INBRX-106 ph2 data on Monday. This is the ox40 cancer drug that reportedly drew interest from Merck and others?

By Adam Feuerstein
HawkEye 360 Raises $416M in IPO
NewsMay 8, 2026

HawkEye 360 Raises $416M in IPO

HawkEye 360 raised $416 million in its NYSE IPO, pricing 16 million shares at $26 each and achieving a $2.4 billion valuation. The offering, led by Goldman Sachs and Morgan Stanley, includes a 30‑day green‑shoe option for an extra 2.4 million shares, potentially adding...

By Payload
Watchlist Targets Underperforming Growth Stocks for Activist Takeovers
SocialMay 8, 2026

Watchlist Targets Underperforming Growth Stocks for Activist Takeovers

I created a watchlist on @InfoArbMonitor to track news of stocks that just can't ever deliver their communicated growth plans just in case new management or activists get involved... First nominees: $SRTS $ULBI https://t.co/sJVOyNHDyO

By Maj Soueidan
PTCT Jumps 17% on Strong Drug Uptake
SocialMay 8, 2026

PTCT Jumps 17% on Strong Drug Uptake

$PTCT up 17% on results, really liked that one after writing up this week, nice value with strong uptake in its new drug, and those Jan. calls kept accumulating https://t.co/HEe8G2Sjdx

By Joe Kunkle
Forward Air, Looking a Bit Yellow-Like – Money’s Too Tight (to Mention)
NewsMay 8, 2026

Forward Air, Looking a Bit Yellow-Like – Money’s Too Tight (to Mention)

Forward Air Corp. (NASDAQ:FWRD) saw its shares tumble 45% in after‑hours trading, sinking to $9.50 – a multi‑year low – after releasing a modest Q1 2026 earnings update. The company disclosed that cash remains tight, prompting concerns about its ability...

By The Loadstar
Smallcaps Show 24.5% Median PAT Growth So Far
SocialMay 8, 2026

Smallcaps Show 24.5% Median PAT Growth So Far

Smallcap results this far: 96/250 out, median PAT growth is 24.5%! Interesting data from thewrap https://t.co/mcytFgtkxe

By Deepak Shenoy
Momentum Persists as Small Caps Join the Rally
SocialMay 8, 2026

Momentum Persists as Small Caps Join the Rally

Here's an updated version of our @CarsonResearch Quilt Chart. Momentum doing what it does, but nice to see smalls join the party. https://t.co/T9KO9Uho9R

By Ryan Detrick
Bull of the Day: LB Foster (FSTR)
NewsMay 8, 2026

Bull of the Day: LB Foster (FSTR)

L.B. Foster (FSTR) posted a Q1 2026 earnings beat, with revenue climbing 23.9% to $121.1 million and EPS turning positive at $0.14. The company’s backlog rose 10.7% sequentially to $209.6 million, and management reaffirmed 2026 guidance of $540‑$580 million revenue and $41‑$46 million adjusted...

By Nasdaq — Investing
Open Square Q1 Gains 48% Amid Oil Surge
SocialMay 8, 2026

Open Square Q1 Gains 48% Amid Oil Surge

Very interesting read from Open Square's Q1 letter. +48% in Q1 🔥🔥 Lots of 🛢️🛢️ https://t.co/rlouN1RiIx

By ToffCap
Forward Air Plunges 45% After Hours, Covenant Default Risk
SocialMay 8, 2026

Forward Air Plunges 45% After Hours, Covenant Default Risk

Forward Air got obliterated in after hours. Down 45% today. Risk of default to bank covenants. https://t.co/wh6l8IW59O

By Craig Fuller
Odyssey Therapeutics Upsizes IPO to 15.5 Million Shares at $18, Raising $304 Million
NewsMay 8, 2026

Odyssey Therapeutics Upsizes IPO to 15.5 Million Shares at $18, Raising $304 Million

Odyssey Therapeutics announced an upsized initial public offering of 15.5 million shares at $18 per share, granting underwriters a 30‑day option for an additional 2.33 million shares and completing a concurrent private placement of 1.39 million shares to a TPG Life Sciences affiliate....

By Pulse
KEN Poised for 10x Gain From 2.6p Entry
SocialMay 8, 2026

KEN Poised for 10x Gain From 2.6p Entry

Bl##dy annoying as was on 2.92p bid for 500k #KEN. This is worth between 10p and 30p depending on partners chosen. Will be a 10 bagger from my entry at 2.6p. A cheeky 2m shares bought so I’m happy . Not too late...

By Pat Vieira
Scatec Shares Fall After Results – Global Group Advances Ipp Strategy Shift
NewsMay 8, 2026

Scatec Shares Fall After Results – Global Group Advances Ipp Strategy Shift

Scatec posted a 31% drop in Q1 2026 revenue to NOK 1.64 bn (≈$180 m) and a 44% decline in EBITDA to NOK 774 m (≈$85 m) as it pivots from one‑off project sales to an integrated independent power producer (IPP) model. Despite weaker earnings, electricity...

By Renewable Energy Industry
Diversified Energy: A Good Deal in More Ways Than One
BlogMay 8, 2026

Diversified Energy: A Good Deal in More Ways Than One

Diversified Energy (DEC) posted a $161 million net loss for Q1 2026, a figure heavily skewed by a $398 million non‑cash derivative charge. Underlying operating cash flow remains strong, and the company leveraged a $1.18 billion Camino acquisition through a Carlyle‑backed SPV that keeps...

By Compounding Capital
Solidcore – Good for yet Another 3x?
BlogMay 8, 2026

Solidcore – Good for yet Another 3x?

Solidcore, the former Polymetal International, has shed its Russian assets for $3.7 bn and refocused on Kazakh gold mines, producing about 500,000 ounces annually. The company now trades at roughly 1.8× 2026 EV/EBITDA, a 60% discount to comparable emerging‑market miners, and...

By Undervalued Shares
Buying Illiquid Japanese Stock Because It's Extremely Cheap
SocialMay 8, 2026

Buying Illiquid Japanese Stock Because It's Extremely Cheap

I’m the same camp as Altay re Solekia $9867 I would normally never hold such an illiquid small Japanese company. But it’s just too damn cheap. https://t.co/YIZjjOpfF2

By ToffCap
Management‑Backed BUC Purchase Targets 7.2p Upside
SocialMay 8, 2026

Management‑Backed BUC Purchase Targets 7.2p Upside

Bought some #BUC in the placing at 1.5p. Management are very large holders and added in this placing. Allenby fair value price target is 7.2p.

By Pat Vieira
The IPO Buzz: Odyssey Therapeutics Prices Upsized IPO at $18 – Stock Pops & Drops
BlogMay 8, 2026

The IPO Buzz: Odyssey Therapeutics Prices Upsized IPO at $18 – Stock Pops & Drops

Odyssey Therapeutics priced its IPO at the top of the $16‑$18 range, selling 15.5 million shares for $18 each and raising roughly $279 million. The Boston‑based biotech debuted on Nasdaq at $20, an 11% first‑day gain, before slipping back to the issue...

By IPO Scoop
MUEL's $15.4M Tender Offer Signals Massive Expansion
SocialMay 8, 2026

MUEL's $15.4M Tender Offer Signals Massive Expansion

Man, @GeoInvesting model portfolio holding, $MUEL is a beast. Another freaking tender offer... $15.4M at $440 per share, following 3 since 2024 ($80 $250 $485). Can't recall seeing anything like this. Look forward to capcity expansions contributing soon. https://t.co/1X2Mu265Gm https://t.co/wTYuZi6mli

By Maj Soueidan
Starz Q1 Loss Widens to $165 M as Streaming and Linear Revenues Slip
NewsMay 8, 2026

Starz Q1 Loss Widens to $165 M as Streaming and Linear Revenues Slip

Starz reported a $165 million net loss for the quarter ended March 31, 2026, as total revenue fell 7% to $307 million and streaming and linear earnings declined. The company also announced it is ending its Pay‑2 film licensing deal with Universal, moving...

By Pulse
Odyssey Raises More than $300M as Biotech Goes Public
NewsMay 8, 2026

Odyssey Raises More than $300M as Biotech Goes Public

Odyssey Therapeutics completed a Nasdaq debut, raising $279 million by selling 15.5 million shares in its initial public offering. The biotech, focused on autoimmune‑disease therapeutics, priced the offering at $18 per share, above the $16.50 low end of its range. Proceeds will...

By Endpoints News
Asara Resources Raises $60m to Fast-Track Kada Gold Project Exploration
NewsMay 8, 2026

Asara Resources Raises $60m to Fast-Track Kada Gold Project Exploration

Asara Resources secured a $60 million institutional placement to accelerate exploration at its flagship Kada Gold Project in Guinea. The funding, issued at $0.125 per share in two tranches, will support resource extension, infill drilling and broader regional programs, with $50 million...

By Small Caps Mining
SoundHound’s Stock Falls as Acquisitions Weigh on Earnings Results
NewsMay 8, 2026

SoundHound’s Stock Falls as Acquisitions Weigh on Earnings Results

SoundHound AI reported Q1 revenue of $44.2 million, up 52% year‑over‑year and ahead of the $42.6 million consensus, but posted an adjusted loss of 6 cents per share, missing the 4‑cent expectation. The earnings miss sent the stock down 12% in after‑hours trading....

By MarketWatch – Top Stories
Esperion Therapeutics Inc (ESPR) Q1 2026 Earnings Call Transcript
NewsMay 8, 2026

Esperion Therapeutics Inc (ESPR) Q1 2026 Earnings Call Transcript

Esperion Therapeutics reported a strong Q1 2022 performance, with total revenue jumping 135% year‑over‑year to $18.8 million, driven by product sales up 109% to $13.4 million and partner revenue soaring 244%. The company achieved 32% cost‑savings in operating expenses and reduced R&D...

By Motley Fool – Earnings Transcripts
CG Oncology Inc (CGON) Q1 2026 Earnings Call Transcript
NewsMay 8, 2026

CG Oncology Inc (CGON) Q1 2026 Earnings Call Transcript

Champions Oncology reported Q1 fiscal 2026 revenue of $14 million, essentially flat year‑over‑year and a rebound from the $12.4 million in the prior quarter. GAAP operating loss of $0.5 million contrasted with a modest positive adjusted EBITDA of $60 k, down sharply from $2 million...

By Motley Fool – Earnings Transcripts
Calumet Inc (CLMT) Q1 2026 Earnings Call Transcript
NewsMay 8, 2026

Calumet Inc (CLMT) Q1 2026 Earnings Call Transcript

Calumet reported full‑year 2025 adjusted EBITDA of $293 million, roughly a 30 % increase year‑over‑year, while slashing restricted debt by more than $220 million and improving net leverage to 4.9 ×. The company closed a Department of Energy loan for its Montana Renewables unit,...

By Motley Fool – Earnings Transcripts
Network-1 Technologies Inc (NTIP) Q1 2026 Earnings Call Transcript
NewsMay 8, 2026

Network-1 Technologies Inc (NTIP) Q1 2026 Earnings Call Transcript

Network-1 Technologies reported a 15.3% rise in total consolidated net sales to $22.0 million, driven by a 72.1% surge in ZERUST Oil & Gas sales and solid growth across industrial and bioplastic segments. Joint‑venture revenue jumped 18.6% to $23.5 million,...

By Motley Fool – Earnings Transcripts